Tom Chadwick
@thomasbchadwick.bsky.social
PhD candidate at @petermaccc.bsky.social & UniMelb 🇦🇺 | Studying IFN signalling in breast cancer metastasis 🦴🧬 | Member of the Parker Lab | Kings College London alum |🔬🏀
Reposted by Tom Chadwick
Peter Mac has been named Australia's leading #cancer research institute in The Australian newspaper's Research 2025 Magazine, and four of our researchers were named as leader in their field.
Read more: www.petermac.org/about-us/new...
Read more: www.petermac.org/about-us/new...
November 27, 2024 at 2:29 AM
Peter Mac has been named Australia's leading #cancer research institute in The Australian newspaper's Research 2025 Magazine, and four of our researchers were named as leader in their field.
Read more: www.petermac.org/about-us/new...
Read more: www.petermac.org/about-us/new...
Reposted by Tom Chadwick
The hallmarks of cancer immune evasion
www.cell.com/cancer-cell/...
www.cell.com/cancer-cell/...
The hallmarks of cancer immune evasion
Cancer cells often evade the host immune system, challenging the effectiveness of
immunotherapy. In this comprehensive review, Galassi et al. summarize key mechanisms
of immune evasion within the “thr...
www.cell.com
November 24, 2024 at 3:03 PM
The hallmarks of cancer immune evasion
www.cell.com/cancer-cell/...
www.cell.com/cancer-cell/...
Just sharing to my new BlueSky followers the review we published a couple of months ago. I think it summarises the topics we look at in our lab well and highlights the complexity of immune evasion in the metastatic cascade
🦴🧠🫁🧬
➡️ www.nature.com/articles/s41...
🦴🧠🫁🧬
➡️ www.nature.com/articles/s41...
The complexity of immune evasion mechanisms throughout the metastatic cascade - Nature Immunology
This Review on the interplay between the immune system and metastasis is part of our wider Series of Reviews on Cancer Immunology and Immunotherapy.
www.nature.com
November 22, 2024 at 4:37 AM
Just sharing to my new BlueSky followers the review we published a couple of months ago. I think it summarises the topics we look at in our lab well and highlights the complexity of immune evasion in the metastatic cascade
🦴🧠🫁🧬
➡️ www.nature.com/articles/s41...
🦴🧠🫁🧬
➡️ www.nature.com/articles/s41...
Reposted by Tom Chadwick
Peter Mac is excited to join BlueSky! 🦋 We look forward to sharing ideas, fostering positivity, and connecting with you all as we work together to advance cancer care and research. Let’s inspire, collaborate, and make a difference!
November 21, 2024 at 12:23 AM
Peter Mac is excited to join BlueSky! 🦋 We look forward to sharing ideas, fostering positivity, and connecting with you all as we work together to advance cancer care and research. Let’s inspire, collaborate, and make a difference!
Reposted by Tom Chadwick
For ECRs going to Lorne Cancer 2025 - Rego & abstract submission is now open for the 2025 OzMRS ECR Symposium on Feb 12 - Join us for a day of extraordinary metastasis research!
Talks, flash talks and poster presentations are available. Abstract deadline is Dec 6. www.ozmrs.com/2025-ecr-sym...
Talks, flash talks and poster presentations are available. Abstract deadline is Dec 6. www.ozmrs.com/2025-ecr-sym...
November 19, 2024 at 7:57 PM
For ECRs going to Lorne Cancer 2025 - Rego & abstract submission is now open for the 2025 OzMRS ECR Symposium on Feb 12 - Join us for a day of extraordinary metastasis research!
Talks, flash talks and poster presentations are available. Abstract deadline is Dec 6. www.ozmrs.com/2025-ecr-sym...
Talks, flash talks and poster presentations are available. Abstract deadline is Dec 6. www.ozmrs.com/2025-ecr-sym...